Serum CD59: a novel biomarker of idiopathic pulmonary fibrosis?
Sign Up to like & getrecommendations! Published in 2020 at "Panminerva medica"
DOI: 10.23736/s0031-0808.20.03893-8
Abstract: BACKGROUND Idiopathic pulmonary fibrosis (IPF) is the most common among idiopathic interstitial pneumonia. Life expectancy is estimated around 3-5 years at diagnosis. No reliable prognostic biomarker has been approved for routinary clinical practice of IPF.… read more here.
Keywords: serum; pulmonary fibrosis; serum cd59; idiopathic pulmonary ... See more keywords